Biotech

All Articles

Galapagos stops CAR-T tissue therapy trial over Parkinsonism scenario

.Galapagos has actually stopped enrollment in a trial of a BCMA-directed CAR-T cell therapy, pushing...

James Wilson leaving Penn to release 2 brand-new biotechs

.After much more than three decades, genetics therapy pioneer James Wilson M.D., Ph.D., is actually ...

3 biotechs try to beat the summer season warmth by shedding workers

.As biotechs attempt to turn a fresh webpage in August, at the very least 3 firms have actually lost...

venBio lifts $528M for 5th life scientific researches VC fund

.Veteran venture capital company venBio has lifted yet another half a billion dollars to buy biotech...

Otsuka pays for $800M for Jnana and also its clinical-stage PKU medicine

.Otsuka Pharmaceutical has actually grabbed Boston-based Jnana Rehabs for $800 million so the Japane...

FibroGen lays off 75% of US staff as asset flunks 2 additional trials

.FibroGen is actually radically restructuring its own business, laying off 75% of its united state p...

Tracon winds down full weeks after injectable PD-L1 inhibitor stop working

.Tracon Pharmaceuticals has actually decided to wane procedures full weeks after an injectable immun...

Ideaya bags alternative on Biocytogen bispecific ADC in $400M package

.Ideaya Biosciences is actually wagering $400 million in biobucks that a bispecific antibody-drug co...

Takeda takes $140M loss on failed epilepsy medication, touts FDA operate

.Our experts currently understand that Takeda is actually wanting to discover a course to the FDA fo...

VBI Vaccines files for insolvency, looks for possession purchase

.Immunology biotech VBI Injections is actually drifting alarmingly close to the point of no return, ...